Premium
Emergency Contraception: A Reasonable Personal Choice or a Destructive Societal Influence?
Author(s) -
Greene M F
Publication year - 2008
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.6100433
Subject(s) - emergency contraception , food and drug administration , agency (philosophy) , clinical pharmacology , levonorgestrel , medical prescription , administration (probate law) , politics , medicine , medical emergency , family planning , political science , law , pharmacology , sociology , environmental health , population , research methodology , social science
A 2003 petition to the US Food and Drug Administration by the manufacturer to move levonorgestrel emergency contraception from prescription status to over‐the‐counter sale embroiled the Agency in politics and remains controversial in some circles. This essay addresses the current remaining main points of contoversy about the medication and the Agency's decision. Clinical Pharmacology & Therapeutics (2008) 83 , 17–19; doi: 10.1038/sj.clpt.6100433